Protectors for vascular calcification among CKD patients included Lanthanum carbonate [63], calcimimetic agent [64], kloth [13], pyrophosphate [65], osteoprotegerin [66], and RANK-L [66]. This evidence concerns the gene TNFSF11 and chronic kidney disease.